1
|
Zhang X, Nie H, Whited J, Wang D, Li Y, Sun XL. Recent approaches for directly profiling cell surface sialoform. Glycobiology 2019; 28:910-924. [PMID: 29800278 DOI: 10.1093/glycob/cwy046] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Accepted: 05/09/2018] [Indexed: 12/13/2022] Open
Abstract
Sialic acids (SAs) are nine-carbon monosaccharides existing at the terminal location of glycan structures on the cell surface and secreted glycoconjugates. The expression levels and linkages of SAs on cells and tissues, collectively known as sialoform, present the hallmark of the cells and tissues of different systems and conditions. Accordingly, detecting or profiling cell surface sialoforms is very critical for understanding the function of cell surface glycans and glycoconjugates and even the molecular mechanisms of their underlying biological processes. Further, it may provide therapeutic and diagnostic applications for different diseases. In the past decades, several kinds of SA-specific binding molecules have been developed for detecting and profiling specific sialoforms of cells and tissues; the experimental materials have expanded from frozen tissue to living cells; and the analytical technologies have advanced from histochemistry to fluorescent imaging, flow cytometry and microarrays. This review summarizes the recent bioaffinity approaches for directly detecting and profiling specific SAs or sialylglycans, and their modifications of different cells and tissues.
Collapse
Affiliation(s)
- Xiaoqing Zhang
- School of Life Science and Technology, Harbin Institute of Technology, 2 Yikuang-jie, Harbin, Heilongjiang, China
| | - Huan Nie
- School of Life Science and Technology, Harbin Institute of Technology, 2 Yikuang-jie, Harbin, Heilongjiang, China
| | - Joshua Whited
- Department of Chemistry, Chemical and Biomedical Engineering and Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, 2121 Euclid Avenue, Cleveland, OH, USA
| | - Dan Wang
- Department of Chemistry, Chemical and Biomedical Engineering and Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, 2121 Euclid Avenue, Cleveland, OH, USA
| | - Yu Li
- School of Life Science and Technology, Harbin Institute of Technology, 2 Yikuang-jie, Harbin, Heilongjiang, China
| | - Xue-Long Sun
- Department of Chemistry, Chemical and Biomedical Engineering and Center for Gene Regulation in Health and Disease (GRHD), Cleveland State University, 2121 Euclid Avenue, Cleveland, OH, USA
| |
Collapse
|
2
|
Ben Khelifa M, Coutton C, Zouari R, Karaouzène T, Rendu J, Bidart M, Yassine S, Pierre V, Delaroche J, Hennebicq S, Grunwald D, Escalier D, Pernet-Gallay K, Jouk PS, Thierry-Mieg N, Touré A, Arnoult C, Ray PF. Mutations in DNAH1, which encodes an inner arm heavy chain dynein, lead to male infertility from multiple morphological abnormalities of the sperm flagella. Am J Hum Genet 2014; 94:95-104. [PMID: 24360805 DOI: 10.1016/j.ajhg.2013.11.017] [Citation(s) in RCA: 299] [Impact Index Per Article: 27.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2013] [Accepted: 11/18/2013] [Indexed: 11/30/2022] Open
Abstract
Ten to fifteen percent of couples are confronted with infertility and a male factor is involved in approximately half the cases. A genetic etiology is likely in most cases yet only few genes have been formally correlated with male infertility. Homozygosity mapping was carried out on a cohort of 20 North African individuals, including 18 index cases, presenting with primary infertility resulting from impaired sperm motility caused by a mosaic of multiple morphological abnormalities of the flagella (MMAF) including absent, short, coiled, bent, and irregular flagella. Five unrelated subjects out of 18 (28%) carried a homozygous variant in DNAH1, which encodes an inner dynein heavy chain and is expressed in testis. RT-PCR, immunostaining, and electronic microscopy were carried out on samples from one of the subjects with a mutation located on a donor splice site. Neither the transcript nor the protein was observed in this individual, confirming the pathogenicity of this variant. A general axonemal disorganization including mislocalization of the microtubule doublets and loss of the inner dynein arms was observed. Although DNAH1 is also expressed in other ciliated cells, infertility was the only symptom of primary ciliary dyskinesia observed in affected subjects, suggesting that DNAH1 function in cilium is not as critical as in sperm flagellum.
Collapse
Affiliation(s)
- Mariem Ben Khelifa
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France; Laboratoire de génomique Biomédicale et Oncogénétique, Institut Pasteur de Tunis, 1002 Tunis, Tunisie
| | - Charles Coutton
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France; CHU de Grenoble, Hôpital Couple Enfant, Département de Génétique et Procréation, Laboratoire de Génétique Chromosomique, Grenoble 38000, France
| | - Raoudha Zouari
- Clinique des Jasmins, 23, Av. Louis BRAILLE, 1002 Tunis, Tunisia
| | - Thomas Karaouzène
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France
| | - John Rendu
- Université Joseph Fourier, Grenoble 38000, France; CHU de Grenoble, Institut de Biologie et Pathologie, Département de Biochimie, Toxicologie et Pharmacologie (DBTP), UF de Biochimie et Génétique Moléculaire, Grenoble 38000, France; INSERM, U836, Grenoble Institute of Neuroscience, La Tronche 38700, France
| | - Marie Bidart
- Université Joseph Fourier, Grenoble 38000, France; INSERM, U836, Grenoble Institute of Neuroscience, La Tronche 38700, France
| | - Sandra Yassine
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France
| | - Virginie Pierre
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France
| | - Julie Delaroche
- Université Joseph Fourier, Grenoble 38000, France; INSERM, U836, Grenoble Institute of Neuroscience, La Tronche 38700, France
| | - Sylviane Hennebicq
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France; CHU de Grenoble, Hôpital Couple Enfant, Département de Génétique et Procréation, Laboratoire d'Aide à la Procréation - CECOS, Grenoble 38000, France
| | - Didier Grunwald
- Université Joseph Fourier, Grenoble 38000, France; INSERM, U836, Grenoble Institute of Neuroscience, La Tronche 38700, France
| | - Denise Escalier
- INSERM UMR_S933, Université Pierre et Marie Curie (Paris 6), Paris 75012, France
| | - Karine Pernet-Gallay
- Université Joseph Fourier, Grenoble 38000, France; INSERM, U836, Grenoble Institute of Neuroscience, La Tronche 38700, France
| | - Pierre-Simon Jouk
- Université Joseph Fourier-Grenoble 1 / CNRS / TIMC-IMAG UMR 5525, Grenoble 38041, France; CHU de Grenoble, Hôpital Couple Enfant, Département de Génétique et Procréation, Service de Génétique Clinique, Grenoble 38000, France
| | - Nicolas Thierry-Mieg
- Université Joseph Fourier-Grenoble 1 / CNRS / TIMC-IMAG UMR 5525, Grenoble 38041, France
| | - Aminata Touré
- INSERM, U1016, Institut Cochin, Paris 75014, France; CNRS, UMR8104, Paris 75014, France; Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris 75014, France
| | - Christophe Arnoult
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France
| | - Pierre F Ray
- Université Joseph Fourier, Grenoble 38000, France; Laboratoire AGIM, CNRS FRE3405, Equipe "Andrologie et Génétique," La Tronche 38700, France; CHU de Grenoble, Institut de Biologie et Pathologie, Département de Biochimie, Toxicologie et Pharmacologie (DBTP), UF de Biochimie et Génétique Moléculaire, Grenoble 38000, France.
| |
Collapse
|
3
|
Joshi CS, Suryawanshi AR, Khan SA, Balasinor NH, Khole VV. Liprin α3: a putative estrogen regulated acrosomal protein. Histochem Cell Biol 2012; 139:535-48. [PMID: 23124857 DOI: 10.1007/s00418-012-1044-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/16/2012] [Indexed: 11/28/2022]
Abstract
Liprin α3 was reported for the first time using sperm proteomics. Present study reports its localization on sperm and immunochemical characterization. Liprin α3 is identified as a 133 kDa protein in testis and epididymal protein extracts. In testis, immunohistochemical localization was seen in pachytenes, diplotenes, round spermatids whereas it was localized in the epithelial cells and luminal sperm in all the three regions of epididymis. Protein was localized in acrosome of rat sperm, which was further confirmed by sequential treatment of sperm with hypertonic solution. In the spermatogenic cells the protein was found to be located in developing acrosome as evident by its co-localization with Golgi marker. Protein was found to be developmentally regulated. In silico analysis of Liprin α3 revealed presence of the estrogen responsive elements upstream to initiation site and its regulation by estrogen was experimentally validated using a tamoxifen treated rat model. Western blot analysis of epididymosomes showed the presence of Liprin α3, indicating its involvement in trafficking of vesicle. The protein expression was seen in both mouse and human sperm indicating conserved nature and a probable role in acrosome reaction.
Collapse
Affiliation(s)
- Chetanchandra S Joshi
- Department of Gamete Immunobiology, National Institute for Research in Reproductive Health (ICMR), J. M. Street, Parel, Mumbai, 400012, India
| | | | | | | | | |
Collapse
|
4
|
Capková J, Elzeinová F, Novák P. Increased expression of secretory actin-binding protein on human spermatozoa is associated with poor semen quality. Hum Reprod 2007; 22:1396-404. [PMID: 17251356 DOI: 10.1093/humrep/del511] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Antibodies to human sperm are useful diagnostic reagents for detection of changes in sperm protein expression and their relationship with sperm defects and male infertility. The specificity of Hs-16 monoclonal antibody (mAb) and the localization and frequency of the occurrence of Hs-16-recognized protein on human spermatozoa were investigated. METHODS Samples from 30 fertile men with normal spermiograms and 30 men with pathological spermiograms were studied. The specificity of Hs-16 mAb was analysed by the western blotting technique and matrix-assisted laser desorption/ionization mass spectrometry. Indirect immunofluorescence with Hs-16 antibody was used to test sperm ejaculates. RESULTS The Hs-16 antibody detected a human sperm and seminal plasma protein, which was determined to be secretory actin-binding protein (SABP). This specificity was also verified by co-localization of SABP and actin on spermatozoa with Hs-16 and anti-actin antibodies, and partial co-localization of these proteins was found. SABP was localized on the sperm tail, mainly in the midpiece of the tail. Other parts of spermatozoa were labelled with lower frequency. A significant difference was found in SABP labelling between men with normal spermiograms and donors with asthenozoospermia or oligoasthenoteratozoospermia (both P < 0.01), and asthenozoospermia versus oligoasthenoteratozoospermia (P < 0.05). Increased expression of SABP was observed in men with pathological spermiograms. CONCLUSIONS Hs-16 antibody reacts specifically with SABP. SABP can serve as a marker of defective sperm and may be associated with fertility failure.
Collapse
Affiliation(s)
- Jana Capková
- Department of Biology and Biochemistry of Fertilization, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
| | | | | |
Collapse
|
8
|
Catalano RD, Hillhouse EW, Vlad M. Developmental expression and characterization of FS39, a testis complementary DNA encoding an intermediate filament-related protein of the sperm fibrous sheath. Biol Reprod 2001; 65:277-87. [PMID: 11420250 DOI: 10.1095/biolreprod65.1.277] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
Proteins immunologically related to intermediate filaments have been identified in the sperm fibrous sheath but remain uncharacterized. We isolated and characterized a novel intermediate filament-related protein (FS39) localized to the fibrous sheath of the sperm tail. We used Northern blot analysis to establish that FS39 is transcribed predominantly in the testis of mice >18-20 days old. At this age, spermatogenesis has proceeded to the development of the first round haploid spermatids. In situ hybridization revealed that FS39 mRNA is first detectable in late step 3 spermatids, is at its highest level during steps 9 and 10, and diminishes in steps 13 and 14. Western blot analysis identified a single protein of 39 kDa in mouse and rat testis and epididymis, suggesting the protein is conserved in rodents. Indirect immunofluorescence localized FS39 to the fibrous sheath of the sperm tail, and in testis sections expression was detected from step 13 and step 14 spermatids onward, indicating FS39 is under translational control. Southern blot analysis showed FS39 to be a single copy gene, and hybridization to human genomic DNA suggested that a human equivalent gene is present. These results demonstrate that FS39 is transcribed in testis tissue during the haploid phase of spermatogenesis, is present in mature sperm, and codes for a novel 39-kDa intermediate filament-related protein of the fibrous sheath.
Collapse
Affiliation(s)
- R D Catalano
- Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom.
| | | | | |
Collapse
|
9
|
Mandal A, Naaby-Hansen S, Wolkowicz MJ, Klotz K, Shetty J, Retief JD, Coonrod SA, Kinter M, Sherman N, Cesar F, Flickinger CJ, Herr JC. FSP95, a testis-specific 95-kilodalton fibrous sheath antigen that undergoes tyrosine phosphorylation in capacitated human spermatozoa. Biol Reprod 1999; 61:1184-97. [PMID: 10529264 DOI: 10.1095/biolreprod61.5.1184] [Citation(s) in RCA: 130] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
Protein tyrosine phosphorylation has been associated with both capacitation and motility of mammalian sperm. During capacitation, human spermatozoa undergo tyrosine phosphorylation of a characteristic set of proteins, only one of which has thus far been cloned and localized. We report here the sequence of a fibrous sheath protein of 95 kDa (FSP95) that undergoes tyrosine phosphorylation during capacitation of human spermatozoa and has similarity to sperm A-kinase anchor proteins (AKAPs). FSP95 is both auto- and iso-antigenic in humans as it is recognized by sera containing antisperm antibodies from infertile men and women. The 853-residue protein has a calculated molecular weight of 94.6 kDa and an isoelectric point (pI) of 6.0, and it contains multiple potential phosphorylation sites for protein kinase C and casein kinase II as well as one potential tyrosine kinase phosphorylation site at amino acid 435. The sequence has amino acid homology to mouse sperm fibrous sheath AKAP82 (pro-mAKAP82, 34% identity) and to human sperm fibrous sheath AKAP82 (pro-hAKAP82, 32% identity). The gene encoding FSP95 has 5 exons separated by 4 introns and is located on chromosome 12 at locus p13.3. Northern analysis detected a single transcript of approximately 3.0 kilobases, and Northern dot blot analysis of 50 human tissues revealed FSP95 mRNA expression only in testis. By employing sperm immobilization, indirect immunofluorescence, and immunoelectron microscopy with antisera to purified recombinant FSP95, the protein was localized to the ribs of the fibrous sheath in the principal piece of the sperm tail. FSP95 is the second fibrous sheath protein to be cloned, sequenced and localized in human spermatozoa.
Collapse
Affiliation(s)
- A Mandal
- Center for Recombinant Gamete Contraceptive Vaccinogens, Department of Cell Biology, University of Virginia, Charlottesville, Virginia 22908, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Courtade M, Lagorce C, Bujan L, Caratero C, Mieusset R. Clinical characteristics and light and transmission electron microscopic sperm defects of infertile men with persistent unexplained asthenozoospermia. Fertil Steril 1998; 70:297-304. [PMID: 9696225 DOI: 10.1016/s0015-0282(98)00152-6] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To determine, with the use of transmission electron microscopy (TEM), the proportion of patients with permanent unexplained asthenozoospermia (<30% motility) who have an abnormality of sperm axonemal and periaxonemal structures. DESIGN Retrospective study. SETTING A university-affiliated public hospital. PATIENT(S) Sixty-one infertile men whose semen was submitted to TEM analysis because of persistent unexplained asthenozoospermia. MAIN OUTCOME MEASURE(S) The results of quantitative TEM analysis of the tails of the spermatozoa. INTERVENTION(S) None. RESULT(S) Based on a comparison with the axonemal anomalies observed in nine fertile control patients, the infertile population was divided into three groups: group I, with no detectable axonemal defects (26.2%); group II, with axonemal anomalies in either the midpiece or the principal piece (29.5%); and group III, with axonemal anomalies in both the midpiece and the principal piece (44.3%). However, defects in the mitochondrial sheath, fibrous sheath, and sperm head (acrosomic and postacrosomic cap) were observed in at least 50%, 30%, and 50%, respectively, of the patients in each group. The proportion of dense fiber anomalies of the midpiece increased significantly from group I to group III. No differences were observed between the three groups in sperm characteristics, anamnesis information, or clinical data. CONCLUSION(S) In patients with persistent unexplained asthenozoospermia, the frequent association of periaxonemal anomalies with axonemal deficiencies strongly suggests that axonemal deficiencies are not the unique cause of decreased motility.
Collapse
Affiliation(s)
- M Courtade
- Laboratoire d'Histologie-Embryologie-Cytogénétique, Faculté de Médecine, Hôpital de La Grave, Toulouse, France
| | | | | | | | | |
Collapse
|